Author

D. Peer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 1 Assay:multiome· 1

Frequent Co-Authors

E. Bar-Haim· 3 shared G. S. Naidu· 3 shared O. Cohen· 3 shared U. Elia· 3 shared E. Makdasi· 2 shared M. Aftalion· 2 shared S. Rotem· 2 shared A. Bercovich-Kinori· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

E. Bar-Haim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An Effective mRNA-LNP Vaccine Against the Lethal Plague Bacterium

E. Kon, Y. Levy, U. Elia, H. Cohen, I. Halevy, M. Aftalion, A. Ezra, E. Bar-Haim, G. S. Naidu, Y. Diesendruck, S. Rotem, N. Ad-El, M. Goldsmith, E. Mamroud, D. Peer, O. Cohen

This study develops an mRNA-LNP vaccine against Yersinia pestis, showing it provides full protection against infection in animals.

bioRxiv · Aug 7, 2022 · PreprintMicrobiology

A lipid nanoparticle RBD-hFc mRNA vaccine protects hACE2 transgenic mice against lethal SARS-CoV-2 infection

U. Elia, S. Rotem, E. Bar-Haim, S. Ramishetti, G. S. Naidu, D. Gur, M. Aftalion, M. Israeli, A. Bercovich-Kinori, R. Alcalay, E. Makdasi, T. Chitlaru, R. Rosenfeld, T. Israely, S. Melamed, , O. Cohen

This study evaluates an mRNA vaccine against SARS-CoV-2 in hACE2 transgenic mice, showing 70% protection against a lethal infection.

bioRxiv · Mar 29, 2021Microbiology

Design of SARS-CoV-2 RBD mRNA Vaccine Using Novel Ionizable Lipids

U. Elia, R. Srinivas, N. Dammes, E. Bar-Haim, G. S. Naidu, E. Makdasi, O. Cohen, D. Peer

This study designs an mRNA vaccine targeting SARS-CoV-2 RBD using novel ionizable lipids, showing strong immune responses in mice.

bioRxiv · Oct 15, 2020Immunology